Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast Alone After Breast Conserving Surgery

NCT03324802 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03324802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03324802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast Alone After Breast Conserving Surgery
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
February 7, 2018
Completion date
August 28, 2023
Enrollment
107 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stage i breast cancer ajcc v7, stage ia breast cancer ajcc v7, stage ib breast cancer ajcc v7, stage ii breast cancer ajcc v6 and v7, stage iia breast cancer ajcc v6 and v7, stage iib breast cancer ajcc v6 and v7, stage iiia breast cancer ajcc v7